Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT

Malladi, Srinivas, Macalinao, Danilo G., Jin, Xin, He, Lan, Basnet, Harihar, Zou, Yilong, de Stanchina, Elisa, Massagué, Joan·2016·Cell

Cited by (790)

Items 201–300 of 790

  1. Brain Metastasis Organotropism
    Arseniy E. Yuzhalin, Dihua Yu · 2019 · Cold Spring Harbor Perspectives in Medicine
  2. Dickkopf signaling, beyond Wnt-mediated biology
    Akira Kikuchi, Shinji Matsumoto, Ryota Sada · 2021 · Seminars in Cell and Developmental Biology
  3. Remodeling the ECM: Implications for Metastasis and Tumor Dormancy
    Julie S. Di Martino, Tasmiah Akhter, Jose Javier Bravo‐Cordero · 2021 · Cancers
  4. Immunotherapy resistance in esophageal cancer: Possible mechanisms and clinical implications
    Pinhao Fang, Jianfeng Zhou, Zhiwen Liang, Yu‐Shang Yang, Siyuan Luan, Xin Xiao, Xiaokun Li, Hanlu Zhang, Qixin Shang, Xiaoxi Zeng et al. · 2022 · Frontiers in Immunology
  5. Autophagy and Cancer Dormancy
    Yunus Akkoç, Nesibe Peker, Arzu Akçay, Devrim Gözüaçık · 2021 · Frontiers in Oncology
  6. mDKN-01, a Novel Anti-DKK1 mAb, Enhances Innate Immune Responses in the Tumor Microenvironment
    Michael Haas, Michael H. Kagey, Heidi Heath, Franziska Schuerpf, James B. Rottman, Walter Newman · 2020 · Molecular Cancer Research
  7. Histone modifications in drug-resistant cancers: From a cancer stem cell and immune evasion perspective
    M. Jin, Kwang Won Jeong · 2023 · Experimental and Molecular Medicine
  8. Wnt signaling modulator DKK1 as an immunotherapeutic target in ovarian cancer
    Ilaria Betella, William J. Turbitt, Tomasz Szul, Bing‐Hao Wu, Alba Martínez, Ashwini K. Katre, Jaclyn A. Wall, Lyse A. Norian, Michael J. Birrer, Rebecca Christian Arend · 2020 · Gynecologic Oncology
  9. Dickkopf 1 impairs the tumor response to PD-1 blockade by inactivating CD8+ T cells in deficient mismatch repair colorectal cancer
    Qiaoqi Sui, Dingxin Liu, Jiang Wu, Jinghua Tang, Ling-Heng Kong, Kai Han, Leen Liao, Yuan Li, Qingjian Ou, Binyi Xiao et al. · 2021 · Journal for ImmunoTherapy of Cancer
  10. Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers
    Vito Amodio, Gianluca Mauri, Nicole Megan Reilly, Andrea Sartore Bianchi, Salvatore Siena, Alberto Bardelli, Giovanni Germano · 2021 · Cancers
  11. Quiescent Cancer Cells—A Potential Therapeutic Target to Overcome Tumor Resistance and Relapse
    Emma Lindell, Lei Zhong, Xiaonan Zhang · 2023 · International Journal of Molecular Sciences
  12. LncRNA Malat1 suppresses pyroptosis and T cell-mediated killing of incipient metastatic cells
    Dhiraj Kumar, Sreeharsha Gurrapu, Yan Wang, Seong‐Yeon Bae, Poonam R. Pandey, Hong Chen, Jayanta Mondal, Hyun Ho Han, Chang‐Jiun Wu, Spyros Karaiskos et al. · 2024 · Nature Cancer
  13. New Advances in Canonical Wnt/β-Catenin Signaling in Cancer
    Xiaolan Wen, Yanling Wu, Annoor Awadasseid, Yoshimasa Tanaka, Wen Zhang · 2020 · Cancer Management and Research
  14. Understanding NK cell biology for harnessing NK cell therapies: targeting cancer and beyond
    Eunju Shin, Seong Ho Bak, Taeho Park, Jin-Woo Kim, Suk Ran Yoon, Haiyoung Jung, Ji‐Yoon Noh · 2023 · Frontiers in Immunology
  15. The Biology and Therapeutic Implications of Tumor Dormancy and Reactivation
    Amit Singh Yadav, Poonam R. Pandey, Ramesh Butti, N. N. V. Radharani, Shamayita Roy, Shaileshkumar R. Bhalara, Mahadeo Gorain, Gopal C. Kundu, Dhiraj Kumar · 2018 · Frontiers in Oncology
  16. Estrogen receptors in breast and bone: from virtue of remodeling to vileness of metastasis
    Igor Bado, Zbigniew Gugala, Suzanne A.W. Fuqua, Xuqing Zhang · 2017 · Oncogene
  17. RSPO2 and RANKL signal through LGR4 to regulate osteoclastic premetastatic niche formation and bone metastasis
    Zhiying Yue, Xin Niu, Zengjin Yuan, Qin Qin, Wenhao Jiang, Liang He, Jingduo Gao, Yi Ding, Yanxi Liu, Ziwei Xu et al. · 2022 · White Rose Research Online (University of Leeds, The University of Sheffield, University of York)
  18. A cell cycle centric view of tumour dormancy
    William A. Weston, Alexis R. Barr · 2023 · British Journal of Cancer
  19. Itraconazole targets cell cycle heterogeneity in colorectal cancer
    Simon J. A. Buczacki, Semiramis A. Popova, Emma K. Biggs, Chrysa Koukorava, Jon N. Buzzelli, Louis Vermeulen, Lee D. Hazelwood, Hayley E. Francies, Mathew J. Garnett, Douglas J. Winton · 2018 · The Journal of Experimental Medicine
  20. Vascular co-option in brain metastasis
    Pedro García‐Gómez, Manuel Valiente · 2019 · Angiogenesis
  21. Cancer and Microenvironment Plasticity: Double-Edged Swords in Metastasis
    Xueqian Zhuang, Hao Zhang, Guohong Hu · 2019 · Trends in Pharmacological Sciences
  22. Dickkopf1: An immunomodulatory ligand and Wnt antagonist in pathological inflammation
    Wook‐Jin Chae, Alfred L.M. Bothwell · 2019 · Differentiation
  23. H3K27me3-mediated PGC1α gene silencing promotes melanoma invasion through WNT5A and YAP
    Chi Luo, Eduardo Balsa, Elizabeth A. Perry, Jiaxin Liang, Clint D.J. Tavares, Francisca Vázquez, Hans R. Widlund, Pere Puigserver · 2020 · Journal of Clinical Investigation
  24. Unchecked oxidative stress in skeletal muscle prevents outgrowth of disseminated tumour cells
    Sarah B. Crist, Travis G. Nemkov, Ruth F. Dumpit, Jinxiang Dai, Stephen J. Tapscott, Lawrence D. True, Alexander Swarbrick, Lucas B. Sullivan, Peter S. Nelson, Kirk Charles Hansen et al. · 2022 · Nature Cell Biology
  25. Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate Cancer
    David R. Wise, Jeffrey A. Schneider, Joshua Armenia, Victor Adorno Febles, Bridget E. McLaughlin, Ryan Brennan, Katie L. Thoren, Wassim M. Abida, Karen Sandell Sfanos, Angelo Michael De Marzo et al. · 2020 · JCO Precision Oncology
  26. Genomic control of metastasis
    Saroor A. Patel, Paulo Rodrigues, Ludovic Wesolowski, Sakari Vanharanta · 2020 · British Journal of Cancer
  27. Natural killer cell activity for IFN-gamma production as a supportive diagnostic marker for gastric cancer
    Jongmi Lee, Ki Hyun Park, Ji Hyeong Ryu, Hyun Jin Bae, Ae‐Ran Choi, Hyeyoung Lee, Jihyang Lim, Kyungja Han, Cho Hyun Park, Eun Sun Jung et al. · 2017 · Oncotarget
  28. The anti-DKK1 antibody DKN-01 as an immunomodulatory combination partner for the treatment of cancer
    Jaclyn A. Wall, Samuel Jacob Klempner, Rebecca Christian Arend · 2020 · Expert Opinion on Investigational Drugs
  29. Ecology and evolution of dormant metastasis
    María Teresa Blasco, Irene Espuny, Roger R. Gomis · 2022 · Trends in cancer
  30. Locally sourced: site-specific immune barriers to metastasis
    Ana Luísa Correia · 2023 · Nature reviews. Immunology
  31. Perivascular niches: critical hubs in cancer evolution
    Ada Nowosad, Jean‐Christophe Marine, Panagiotis Karras · 2023 · Trends in cancer
  32. Innovative Approaches in the Battle Against Cancer Recurrence: Novel Strategies to Combat Dormant Disseminated Tumor Cells
    Scott J. Sauer, Damon R. Reed, Michael A. Ihnat, Robert E. Hurst, David Warshawsky, Dalit Barkan · 2021 · Frontiers in Oncology
  33. Cancer Stem Cells in Ovarian Cancer—A Source of Tumor Success and a Challenging Target for Novel Therapies
    Jacek R. Wilczyński, Miłosz Wilczyński, Edyta Paradowska · 2022 · International Journal of Molecular Sciences
  34. Classification of gene signatures for their information value and functional redundancy
    Laura Cantini, Laurence Calzone, Loredana Martignetti, Mattias Rydenfelt, Nils Blüthgen, Emmanuel Barillot, Andrei Y. Zinovyev · 2017 · npj Systems Biology and Applications
  35. Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis
    Andreas Daniel Hartkopf, Sara Yvonne Brucker, Florin‐Andrei Taran, Nadia Harbeck, Alexandra von Au, Bjørn Naume, Jean‐Yves Pierga, Oliver Hoffmann, Matthias W. Beckmann, Lisa Rydén et al. · 2021 · European Journal of Cancer
  36. Decoding the interplay between genetic and non-genetic drivers of metastasis
    Panagiotis Karras, James R. Black, Nicholas McGranahan, Jean‐Christophe Marine · 2024 · Nature
  37. Phase I and Biomarker Study of the Wnt Pathway Modulator DKN-01 in Combination with Gemcitabine/Cisplatin in Advanced Biliary Tract Cancer
    Lipika Goyal, Cynthia A. Sirard, Michael L. Schrag, Michael H. Kagey, Jennifer Rachel Eads, Stacey Stein, Anthony B. El-Khoueiry, Gulam Abbas Manji, Thomas Adam Abrams, Alok A. Khorana et al. · 2020 · Clinical Cancer Research
  38. Phenotypic plasticity during metastatic colonization
    Charly Jehanno, Milica Vulin, Veronica Richina, Federica Richina, Mohamed Bentires‐Alj · 2022 · Trends in Cell Biology
  39. Stemness in solid malignancies: coping with immune attack
    Judith Agudo, Yuxuan Miao · 2024 · Nature reviews. Cancer
  40. Expansion of cancer stem cell pool initiates lung cancer recurrence before angiogenesis
    Lei Li, Jiang-Chao Li, Hong Yang, Xu Zhang, Lulu Liu, Yan Li, Tingting Zeng, Ying-Hui Zhu, Xiao-Dong Li, Yan Li et al. · 2018 · Proceedings of the National Academy of Sciences
  41. Metastatic Spread in Prostate Cancer Patients Influencing Radiotherapy Response
    Daria Klusa, Fabian Lohaus, Giulia Furesi, Martina Rauner, Martina Benešová, Mechthild Krause, Ina Kurth, Claudia Peitzsch · 2021 · Frontiers in Oncology
  42. In vitro Models of Breast Cancer Metastatic Dormancy
    Marco Montagner, Erik A. Sahai · 2020 · Frontiers in Cell and Developmental Biology
  43. Circulating tumor cells as “liquid biopsies” to understand cancer metastasis
    Dennis Woo, Min Yu · 2018 · Translational research
  44. Safety, Efficacy, and Biomarker Results from a Phase Ib Study of the Anti-DKK1 Antibody DKN-01 in Combination with Pembrolizumab in Advanced Esophagogastric Cancers
    Samuel Jacob Klempner, Johanna C. Bendell, Victoria Meucci Villaflor, Laura LaNiel Tenner, Stacey Stein, James B. Rottman, Girish S. Naik, Cynthia A. Sirard, Michael H. Kagey, Marya F. Chaney et al. · 2021 · Molecular Cancer Therapeutics
  45. Inhibition of CCL7 derived from Mo-MDSCs prevents metastatic progression from latency in colorectal cancer
    Xiaoli Ren, Jianbiao Xiao, Wanning Zhang, Feifei Wang, Yan YongRong, Xuehui Wu, Zhicheng Zeng, Yumei He, Wei Yang, Wangjun Liao et al. · 2021 · Cell Death and Disease
  46. Reprogramming to developmental plasticity in cancer stem cells
    Caitlin O’Brien‐Ball, Adrian Biddle · 2017 · Developmental Biology
  47. Microenvironmental Signals and Biochemical Information Processing: Cooperative Determinants of Intratumoral Plasticity and Heterogeneity
    Alexander E. Davies, John G. Albeck · 2018 · Frontiers in Cell and Developmental Biology
  48. Glutathione S‐transferase omega 1 inhibition activates JNK ‐mediated apoptotic response in breast cancer stem cells
    Kanakaraju Manupati, Sudhan Debnath, Kalyan Goswami, Priyanka S. Bhoj, Hemant S. Chandak, Sandeep P. Bahekar, Amitava Das · 2019 · FEBS Journal
  49. Targeting Cancer Stem Cells by Genetically Engineered Chimeric Antigen Receptor T Cells
    Rowa Y. Alhabbab · 2020 · Frontiers in Genetics
  50. Metastatic Colonization: Escaping Immune Surveillance
    Julien Schaller, Judith Agudo · 2020 · Cancers
  51. Wnt Signaling in Osteosarcoma
    Amit Kumar Singla, Jichuan Wang, Rui Yang, David S. Geller, David Mark Loeb, Bang H. Hoang · 2020 · Advances in experimental medicine and biology
  52. Dormancy in Breast Cancer
    Erica Dalla, Amulya Sreekumar, Julio A. Aguirre‐Ghiso, Lewis A. Chodosh · 2023 · Cold Spring Harbor Perspectives in Medicine
  53. SOX9-regulated cell plasticity in colorectal metastasis is attenuated by rapamycin
    Estefanía Carrasco‐García, Lidia Lopez, Paula Aldaz, Sara Arévalo, Juncal Aldaregia, Larraitz Egaña, Luís Bujanda, Martin C. H. Cheung, Nicolàs Samprón, Idoia García et al. · 2016 · Scientific Reports
  54. COX-2 mediates tumor-stromal prolactin signaling to initiate tumorigenesis
    Yu Zheng, Valentine Comaills, Risa Burr, Gaylor Boulay, David Tomoaki Miyamoto, Ben S. Wittner, Erin Emmons, Srinjoy Sil, Michael W. Koulopoulos, Katherine T. Broderick et al. · 2019 · Proceedings of the National Academy of Sciences
  55. Targeting Immune-Mediated Dormancy: A Promising Treatment of Cancer
    Haofan Wang, Shasha Wang, Mei-chang Huang, Xin‐hua Liang, Ya-Jie Tang, Ya‐ling Tang · 2019 · Frontiers in Oncology
  56. Hepatocellular carcinoma after direct-acting antiviral hepatitis C virus therapy: A debate near the end
    Cristina Maria Muzica, C Stanciu, Laura Huiban, Ana-Maria Sîngeap, Catalin Victor Sfarti, Sebastian Zenovia, Camelia Cojocariu, Anca Victorita Trifan · 2020 · World Journal of Gastroenterology
  57. Precision medicine driven by cancer systems biology
    Fabian V. Filipp · 2017 · Cancer and Metastasis Reviews
  58. Leptomeningeal metastatic cells adopt two phenotypic states
    Ján Remšík, Yudan Chi, Xinran Tong, Ugur T. Sener, Camille Derderian, Abigail Park, Fadi S. Saadeh, Tejus Bale, Adrienne Ann Boire · 2020 · Cancer Reports
  59. Breast Cancer Metastatic Dormancy and Relapse: An Enigma of Microenvironment(s)
    Islam E. Elkholi, Andréane Lalonde, Morag Park, Jean‐François Côté · 2022 · Cancer Research
  60. Tumor dormancy as an alternative step in the development of chemoresistance and metastasis - clinical implications
    Federico Rossari, Cristina Zucchinetti, Gabriele Buda, Enrico Orciuolo · 2019 · Cellular Oncology
  61. SOX9 promotes tumor progression through the axis BMI1-p21CIP
    Paula Aldaz, Maddalen Otaegi-Ugartemendia, Ander Saenz‐Antoñanzas, Mikel García-Puga, Manuel Moreno‐Valladares, Juana María Flores, Daniela Gerovska D, Marcos Jesus Araúzo-Bravo, Nicolàs Samprón, Ander Matheu et al. · 2020 · Scientific Reports
  62. β-Catenin inhibition shapes tumor immunity and synergizes with immunotherapy in colorectal cancer
    Caihong Wang, Jingjing Yan, Pan Yin, Liming Gui, Lu Ji, Bin Ma, Wei‐Qiang Gao · 2020 · OncoImmunology
  63. The immune landscape in brain metastasis
    Luca D Schreurs, Alexander F. vom Stein, Stephanie Theresa Jünger, Marco Timmer, Ka‐Won Noh, Reinhard Buettner, Hamid Kashkar, Volker Neuschmelting, Roland Goldbrunner, Phuong‐Hien Nguyen · 2024 · Neuro-Oncology
  64. YAP1 induces bladder cancer progression and promotes immune evasion through IL-6/STAT3 pathway and CXCL deregulation
    Pritam Sadhukhan, Mingxiao Feng, Emily J. Illingworth, Ido Sloma, Akira Ooki, Andrés Matoso, David Sidransky, Burles Avner Johnson, Luigi Marchionni, Fenna C.M. Sillé et al. · 2024 · Journal of Clinical Investigation
  65. CD59 Regulation by SOX2 Is Required for Epithelial Cancer Stem Cells to Evade Complement Surveillance
    Jianfeng Chen, Peipei Ding, Ling Li, Hongyu Gu, Xin Zhang, Long Zhang, Na Wang, Lu Gan, Qi Wang, Wei Zhang et al. · 2016 · Stem Cell Reports
  66. Overcoming immunosuppression in bone metastases
    Zachary Z. Reinstein, Sahithi Pamarthy, Vinay Sagar, Ricardo Borges da Costa, Sarki Abba Abdulkadir, Francis Joseph Giles, Benedito A. Carneiro · 2017 · Critical Reviews in Oncology/Hematology
  67. Breast Cancer Stem Cells: Signaling Pathways, Cellular Interactions, and Therapeutic Implications
    Lei Wang, Zeng Jin, Rohan P. Master, Chandra Kumar Maharjan, Madison Elizabeth Carelock, Tiffany B. A. Reccoppa, Myung‐Chul Kim, Ryan H. Kolb, Weizhou Zhang · 2022 · Cancers
  68. Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer
    Atish Dipankar Choudhury, Lucia Kwak, Alexander Cheung, Kathryn M. Allaire, Jaqueline Marquez, David Dewei Yang, Abhishek Tripathi, Jacqueline M. Kilar, Meredith Flynn, Brianna Maynard et al. · 2024 · Cancer Immunology Research
  69. Natural Killer Cell Regulation of Breast Cancer Stem Cells Mediates Metastatic Dormancy
    Grace G. Bushnell, Deeksha Sharma, Henry C. Wilmot, Michelle Zheng, Toluwaleke D. Fashina, Chloe M. Hutchens, Samuel Osipov, Monika Leigh Burness, Max S. Wicha · 2024 · Cancer Research
  70. The integrated molecular and histological analysis defines subtypes of esophageal squamous cell carcinoma
    Guozhong Jiang, Zhizhong Wang, Zhenguo Cheng, Weiwei Wang, Shuangshuang Lu, Zifang Zhang, Chinedu Anthony Anene, Faraz Khan, Yue Chen, Emma L. Bailey et al. · 2024 · Nature Communications
  71. Evolving functions of Dickkopf-1 in cancer and immunity
    Nikolai Jaschke, Lorenz Christian Hofbauer, Andy Göbel, Tilman D. Rachner · 2020 · Cancer Letters
  72. Lung-specific metastasis: the coevolution of tumor cells and lung microenvironment
    Guixiu Xiao, Xinmin Wang, Zihan Xu, Yanyang Liu, Jing Jing · 2025 · Molecular Cancer
  73. Determinants of Organotropic Metastasis
    Heath A. Smith, Yibin Kang · 2016 · Annual Review of Cancer Biology
  74. The pan-therapeutic resistance of disseminated tumor cells: Role of phenotypic plasticity and the metastatic microenvironment
    Bo Ma, Alan H. Wells, Amanda M. Clark · 2019 · Seminars in Cancer Biology
  75. Wnt/β-Catenin Signaling Pathway as Chemotherapeutic Target in Breast Cancer: An Update on Pros and Cons.
    N. Mukherjee, C. Panda · 2020 · Clinical Breast Cancer
  76. How circulating tumor cluster biology contributes to the metastatic cascade: from invasion to dissemination and dormancy
    Mostafa Nasr, Conor C. Lynch · 2023 · Cancer and Metastasis Reviews
  77. Disseminated cancer cells in breast cancer: Mechanism of dissemination and dormancy and emerging insights on therapeutic opportunities
    Ganesan Ramamoorthi, Krithika Nandakumar Kodumudi, Corey Gallen, Nadia Nocera Zachariah, Amrita B Basu, Gabriella K. Albert, Amber Beyer, Colin Snyder, Doris A. Wiener, Ricardo Lima Barros Costa et al. · 2021 · Seminars in Cancer Biology
  78. Collective metastasis: coordinating the multicellular voyage
    Emma D. Wrenn, Yin Cheng Huang, Kevin Cheung · 2021 · Clinical & Experimental Metastasis
  79. Single-Cell Analysis Unveils the Role of the Tumor Immune Microenvironment and Notch Signaling in Dormant Minimal Residual Disease
    Mahnaz Janghorban, Yuchen Yang, Na Zhao, Clark Hamor, Tuan M. Nguyen, Xiang H.-F. Zhang, Jeffrey M. Rosen · 2021 · Cancer Research
  80. COVID-19–Induced Modifications in the Tumor Microenvironment: Do They Affect Cancer Reawakening and Metastatic Relapse?
    Federica Francescangeli, Maria Laura De Angelis, Marta Baiocchi, Rachele Rossi, Mauro Biffoni, Ann Zeuner · 2020 · Frontiers in Oncology
  81. Lung endothelium exploits susceptible tumor cell states to instruct metastatic latency
    Jakab, Moritz, Lee, Ki Hong, Uvarovskii, Alexey, Ovchinnikova, Svetlana, Kulkarni, Shubhada R., Jakab, Sevinç, Rostalski, Till, Spegg, Carleen, Anders, Simon, Augustin, Hellmut G. · 2024 · Nature Cancer
  82. mTOR pathway occupies a central role in the emergence of latent cancer cells
    Kseniia V. Aleksandrova, Mikhail L. Vorobev, Irina I. Suvorova · 2024 · Cell Death and Disease
  83. Minimal Residual Disease, Metastasis and Immunity
    Jordi Badia-Ramentol, Jenniffer Linares, Andrea Gómez‐Llonín, Alexandre Calon · 2021 · Biomolecules
  84. DKN-01 in Combination With Tislelizumab and Chemotherapy as First-Line Therapy in Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: DisTinGuish
    Samuel Jacob Klempner, Mohamad Bassam Sonbol, Zev A. Wainberg, Hope Elizabeth Uronis, Vi Kien Chiu, Aaron James Scott, Syma Iqbal, Mohamedtaki Abdulaziz Tejani, Vincent M. Chung, Melissa C Stilian et al. · 2024 · Journal of Clinical Oncology
  85. Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition
    Francesca Mateo, Enrique Javier Arenas, H. Aguilar, Jordi Serra-Musach, G Ruiz de Garibay, Jacopo Boni, Miren Maicas, Shisuo Du, Francesco Iorio, Carmen Herranz et al. · 2016 · Oncogene
  86. The novel lncRNA CALIC upregulates AXL to promote colon cancer metastasis
    Yoshihiro Kawasaki, Masaya Miyamoto, Takeaki Oda, Kosuke Matsumura, Lumi Negishi, Ryuichiro Nakato, Sakiko Suda, Naoko Yokota, Katsuhiko Shirahige, Tetsu Akiyama · 2019 · EMBO Reports
  87. Tumor dormancy: EMT beyond invasion and metastasis
    Patrick Aouad, Hazel M. Quinn, Adeline Berger, Cathrin Brisken · 2023 · genesis
  88. The sleeping ugly: Tumour microenvironment's act to make or break the spell of dormancy
    Laurie J. Gay, Ilaria Malanchi · 2017 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  89. Animal models for studying tumor microenvironment (TME) and resistance to lymphocytic infiltration
    Ryuji Yamaguchi, Guy A Perkins · 2018 · Cancer Biology & Therapy
  90. FBX8 promotes metastatic dormancy of colorectal cancer in liver
    Xiaohui Zhu, Feifei Wang, Xuehui Wu, Li Zhou, Zhizhi Wang, Xiaoli Ren, Yangshu Zhou, Fuyao Song, Yunshi Liang, Zhicheng Zeng et al. · 2020 · Cell Death and Disease
  91. Principles of dormancy evident in high-grade serous ovarian cancer
    Trevor G. Shepherd, Frederick A. Dick · 2022 · Cell Division
  92. The anatomic basis of leptomeningeal metastasis
    Morgan E. Freret, Adrienne Ann Boire · 2024 · The Journal of Experimental Medicine
  93. Phase II Study of Adjuvant Immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette–Guerin Plus Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Dose Interferon Alpha 2B in Stages IIB, IIC, and III Cutaneous Melanoma Patients: A Single Institution, Randomized Study
    José Mordoh, María Betina Pampena, Mariana Aris, Paula Alejandra Blanco, Mónica Lombardo, Erika M. von Euw, Soledad Mac Keon, Michelle Yépez Crow, Alicia Bravo, Juan Manuel O’Connor et al. · 2017 · Frontiers in Immunology
  94. CSCs in Breast Cancer—One Size Does Not Fit All: Therapeutic Advances in Targeting Heterogeneous Epithelial and Mesenchymal CSCs
    Andrew Sulaiman, Sarah McGarry, Xianghui Han, Sheng Liu, Lisheng Wang · 2019 · Cancers
  95. Breast Cancer Dormancy in Bone
    Miranda E. Clements, Rachelle W. Johnson · 2019 · Current Osteoporosis Reports
  96. Advances in Lung Cancer Driver Genes Associated With Brain Metastasis
    Yalin Kang, Yu Tong Jin, Qianxia Li, Xianglin Yuan · 2021 · Frontiers in Oncology
  97. SOX2 Drives Bronchial Dysplasia in a Novel Organotypic Model of Early Human Squamous Lung Cancer
    Lúcia L. Correia, Jo-Anne Johnson, Peter K. McErlean, Julien Bauer, Hassan Farah, Doris M. Rassl, Robert Campbell Rintoul, Tariq Sethi, Paul Lavender, Emma L. Rawlins et al. · 2017 · American Journal of Respiratory and Critical Care Medicine
  98. Plasticity and intratumoural heterogeneity of cell surface antigen expression in breast cancer
    Ján Remšík, Radek Fedr, Jiří Navrátil, Lucia Binó, Eva Slabáková, Pavel Fabián, Marek Svoboda, Karel Souček · 2018 · British Journal of Cancer
  99. Engaging plasticity: Differentiation therapy in solid tumors
    Bar-Hai, Neta, Ishay-Ronen, Dana · 2022 · Frontiers in Pharmacology
  100. Targeting the Metastatic Bone Microenvironment by MicroRNAs
    Marie‐Therese Haider, Hanna Taipaleenmäki · 2018 · Frontiers in Endocrinology